Literature DB >> 23074274

Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cells.

Susan Moir1, Suk See De Ravin, Brian H Santich, Jin Young Kim, Jacqueline G Posada, Jason Ho, Clarisa M Buckner, Wei Wang, Lela Kardava, Mary Garofalo, Beatriz E Marciano, Jody Manischewitz, Lisa R King, Surender Khurana, Tae-Wook Chun, Hana Golding, Anthony S Fauci, Harry L Malech.   

Abstract

CD27(+) memory B cells are reduced in the blood of patients with chronic granulomatous disease (CGD) for reasons and consequences that remain unclear. Here we confirm not only decreased CD27(+) but also IgG(+) B cells in the blood of CGD patients compared with healthy donors (HDs). However, among IgG(+) B cells, the ratio of CD27(-) to CD27(+) was significantly higher in CGD patients compared with HDs. Similar to conventional memory B cells, CD27(-)IgG(+) B cells of CGD patients expressed activation markers and had undergone somatic hypermutation, albeit at levels lower than their CD27(+) counterparts. Functional analyses revealed slight reductions in frequencies of total IgG but not influenza-specific memory B-cell responses, as measured by Elispot in CGD patients compared with HDs. Serum IgG levels and influenza-specific antibodies were also normal in these CGD patients. Finally, we provide evidence that influenza-specific memory B cells can be present within the CD27(-)IgG(+) B-cell compartment. Together, these findings show that, despite reduced circulating CD27(+) memory B cells, CGD patients maintain an intact humoral immunologic memory, with potential contribution from CD27(-) B cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23074274      PMCID: PMC3520621          DOI: 10.1182/blood-2012-05-430959

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER.

Authors:  M Margarida Souto-Carneiro; Nancy S Longo; Daniel E Russ; Hong-wei Sun; Peter E Lipsky
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

2.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

Authors:  Shane Crotty; Rachael D Aubert; John Glidewell; Rafi Ahmed
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

Review 3.  Multiple routes to B-cell memory.

Authors:  Kim L Good-Jacobson; David M Tarlinton
Journal:  Int Immunol       Date:  2012-03-26       Impact factor: 4.823

4.  Normal human IgD+IgM- germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts.

Authors:  Y J Liu; O de Bouteiller; C Arpin; F Brière; L Galibert; S Ho; H Martinez-Valdez; J Banchereau; S Lebecque
Journal:  Immunity       Date:  1996-06       Impact factor: 31.745

5.  Circulating human B cells that express surrogate light chains and edited receptors.

Authors:  E Meffre; E Davis; C Schiff; C Cunningham-Rundles; L B Ivashkiv; L M Staudt; J W Young; M C Nussenzweig
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

6.  A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation.

Authors:  Jessie F Fecteau; Geneviève Côté; Sonia Néron
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

7.  Patients with chronic granulomatous disease have a reduced peripheral blood memory B cell compartment.

Authors:  Jack J Bleesing; Margarida M Souto-Carneiro; William J Savage; Margaret R Brown; Cynthia Martinez; Sule Yavuz; Sebastian Brenner; Richard M Siegel; Mitchell E Horwitz; Peter E Lipsky; Harry L Malech; Thomas A Fleisher
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

8.  Clinical and laboratory aspects of chronic granulomatous disease in description of eighteen patients.

Authors:  Eugénia Grilo Carnide; Cristina Abe Jacob; Ana Moschione Castro; Antonio Carlos Pastorino
Journal:  Pediatr Allergy Immunol       Date:  2005-02       Impact factor: 6.377

9.  Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.

Authors:  Thomas Tiller; Eric Meffre; Sergey Yurasov; Makoto Tsuiji; Michel C Nussenzweig; Hedda Wardemann
Journal:  J Immunol Methods       Date:  2007-10-31       Impact factor: 2.303

10.  Regulated expression of BAFF-binding receptors during human B cell differentiation.

Authors:  Jaime R Darce; Bonnie K Arendt; Xiaosheng Wu; Diane F Jelinek
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

View more
  15 in total

Review 1.  Primary antibody deficiencies.

Authors:  Anne Durandy; Sven Kracker; Alain Fischer
Journal:  Nat Rev Immunol       Date:  2013-06-14       Impact factor: 53.106

Review 2.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

3.  Maturational characteristics of HIV-specific antibodies in viremic individuals.

Authors:  Eric Meffre; Aaron Louie; Jason Bannock; Leo J Y Kim; Jason Ho; Cody C Frear; Lela Kardava; Wei Wang; Clarisa M Buckner; Yimeng Wang; Olivia R Fankuchen; Kathleen R Gittens; Tae-Wook Chun; Yuxing Li; Anthony S Fauci; Susan Moir
Journal:  JCI Insight       Date:  2016-03-17

4.  Duox1 Regulates Primary B Cell Function under the Influence of IL-4 through BCR-Mediated Generation of Hydrogen Peroxide.

Authors:  Ryuichi Sugamata; Agnes Donko; Yousuke Murakami; Howard E Boudreau; Chen-Feng Qi; Jaeyul Kwon; Thomas L Leto
Journal:  J Immunol       Date:  2018-12-17       Impact factor: 5.422

5.  Clinical and Molecular Features of Chronic Granulomatous Disease in Mainland China and a XL-CGD Female Infant Patient After Prenatal Diagnosis.

Authors:  Shiyu Wang; Tao Wang; Qingqing Xiang; Min Xiao; Yao Cao; Huan Xu; Shujuan Li; Wen Tian; Xiaodong Zhao; Xuemei Tang; Liping Jiang
Journal:  J Clin Immunol       Date:  2019-08-27       Impact factor: 8.317

Review 6.  Voltage-Gated Proton Channels as Novel Drug Targets: From NADPH Oxidase Regulation to Sperm Biology.

Authors:  Tamara Seredenina; Nicolas Demaurex; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2014-03-17       Impact factor: 8.401

7.  B-cell activating factor (BAFF) is elevated in chronic granulomatous disease.

Authors:  Kabir Matharu; Kol A Zarember; Beatriz E Marciano; Douglas B Kuhns; Christine Spalding; Mary Garofalo; Thomas Dimaggio; Tyra Estwick; Chiung-Yu Huang; Danielle Fink; Debra L Priel; Thomas A Fleisher; Steven M Holland; Harry L Malech; John I Gallin
Journal:  Clin Immunol       Date:  2013-05-22       Impact factor: 3.969

8.  Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.

Authors:  Clare Sun; Xin Tian; Yuh Shan Lee; Sreenivasulu Gunti; Andrew Lipsky; Sarah E M Herman; Dalia Salem; Maryalice Stetler-Stevenson; Constance Yuan; Lela Kardava; Susan Moir; Irina Maric; Janet Valdez; Susan Soto; Gerald E Marti; Mohammed Z Farooqui; Abner L Notkins; Adrian Wiestner; Georg Aue
Journal:  Blood       Date:  2015-09-03       Impact factor: 22.113

9.  Hyper-responsive Toll-like receptor 7 and 9 activation in NADPH oxidase-deficient B lymphoblasts.

Authors:  Shawna McLetchie; Bryan D Volpp; Mary C Dinauer; Janice S Blum
Journal:  Immunology       Date:  2015-09-29       Impact factor: 7.397

10.  Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature.

Authors:  Tiina Kelkka; Deborah Kienhöfer; Markus Hoffmann; Marjo Linja; Kajsa Wing; Outi Sareila; Malin Hultqvist; Essi Laajala; Zhi Chen; Júlia Vasconcelos; Esmeralda Neves; Margarida Guedes; Laura Marques; Gerhard Krönke; Merja Helminen; Leena Kainulainen; Peter Olofsson; Sirpa Jalkanen; Riitta Lahesmaa; M Margarida Souto-Carneiro; Rikard Holmdahl
Journal:  Antioxid Redox Signal       Date:  2014-07-29       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.